This structural selectivity is not a matter of weak binding but rather structural inability to interact with growth hormone receptors
10.1007/s00127-013-0762-3 367 PetakhP.OksenychV.KamyshnaI.BoisakI.LyubomirskayaK.KamyshnyiO
This systematic review aims to evaluate the current in vitro and in vivo evidence regarding the potential applications of platelet-derived products in various domains of male reproductive health, including in vitro spermatogenesis, sperm preservation, treatment of male infertility, mitigation of testicular toxicity, and management of testicular torsion/detorsion (T/D) injury
These include enhancing intracellular TH availability via modulation of transporters such as monocarboxylate transporter 8 (MCT8) and deiodinases (e.g., DIO1), as well as directly targeting ECM remodeling through upregulation of MMP activity, inhibition of HA synthesis, and blockade of integrin-mediated signaling pathways (119121)
European Heart Journal, 31 (22), 27412749